No Data
No Data
Cochlear (ASX:COH) Will Want To Turn Around Its Return Trends
Cochlear Shakes Bear on Revenue Growth Prospects -- Market Talk
Cochlear Target Price Raised 20% to A$305.00/Share by Citi>COH.AU
Cochlear Raised to Neutral From Sell by Citigroup >COH.AU
Australian Healthcare Players See Wage Indexation Benefits, Margin Expansion in Fiscal 2025, Jarden Research Says
Cochlear (ASX:COH) Appoints New CFO Amid Strong Financials and Strategic Buyback Plan
No Data
No Data